Cibc Private Wealth Group, LLC X4 Pharmaceuticals, Inc Transaction History
Cibc Private Wealth Group, LLC
- $51.3 Billion
- Q1 2025
A detailed history of Cibc Private Wealth Group, LLC transactions in X4 Pharmaceuticals, Inc stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 64,988 shares of XFOR stock, worth $211,860. This represents 0.0% of its overall portfolio holdings.
Number of Shares
64,988Holding current value
$211,860% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding XFOR
# of Institutions
14Shares Held
14.5MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY10.7MShares$34.8 Million0.0% of portfolio
-
Ensign Peak Advisors, Inc Salt Lake City, UT2.24MShares$7.29 Million0.0% of portfolio
-
Nea Management Company, LLC Timonium, MD500KShares$1.63 Million0.08% of portfolio
-
Sv Health Investors, LLC Boston, MA311KShares$1.02 Million1.65% of portfolio
-
Ajo Vista, LLC Boston, MA258KShares$839,9190.75% of portfolio
About X4 Pharmaceuticals, Inc
- Ticker XFOR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,646,096
- Market Cap $224M
- Description
- X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...